Organization · Venture Capital
E-merge Capital Partners
E-merge Capital Partners is a specialist venture capital firm based in Solana Beach, California, focused on early-stage medical device companies. It operates a vertically integrated platform that combines capital investment with engineering and manufacturing support.
Overview
What E-merge Capital Partners does
What E-merge Capital Partners is
E-merge Capital Partners is a specialist venture capital firm based in Solana Beach, California, focused on early-stage medical device companies. It operates a vertically integrated platform that combines capital investment with engineering and manufacturing support.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find E-merge Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
E-merge Capital Partners as a funder
Investment thesis
E-merge Capital Partners focuses on capital-efficient, de-risked early-stage investments in medical device companies, leveraging an integrated platform for engineering and manufacturing.
Focus narrative
E-merge Capital Partners invests primarily in early-stage medical device companies, particularly focusing on Class II devices in the cardiovascular and orthopedic sectors. The firm offers expertise in evaluating and de-risking new opportunities, actively supporting its portfolio companies through various stages of development.
Value beyond capital
E-merge Capital Partners adds value to its portfolio companies through its integrated platform, providing in-house engineering, disciplined device development, and manufacturing capabilities. This approach helps to compress time-to-prototype and minimize development costs, while the firm's active operator-investor posture ensures hands-on support in operations and management.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Sectors
- Healthcare · Biotech · Medical Devices
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Traverse Vascular, SinglePass Transseptal, and Boa Medical
Portfolio context
E-merge Capital Partners has invested in several notable medical device technologies, including single-use radiolucent retractors for orthopedic surgery, over-the-wire RF transseptal access technology for electrophysiology, and advanced neuro and peripheral vascular access solutions. Their portfolio also features innovative catheter technology and next-generation percutaneous AVF technology.
Common questions
What to know about E-merge Capital Partners
Upseed classifies E-merge Capital Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.